As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health ...

CVS Health (CVS) has reached a settlement with the U.S. government, requiring the company to pay $37.76M to resolve claims ...

CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained ...

Accetta, senior vice president and chief pharmacy officer at CVS Health, discussed findings of the retailer's 2025 Rx Report, ...

As part of the settlement, CVS admitted and accepted responsibility for certain conduct alleged by the government, including ...

CVS is a strong buy now, with rising earnings, solid dividends, and steady growth prospects despite industry challenges. Read ...

CVS Health stock has seen its consensus analyst price target edge down slightly from $91.52 to $91.48, a reflection of ...

It’s time for a wellness check at CVS Health. Shares of the company are down more than 20% this year as it grapples with higher-than-expected medical costs in its insurance unit and pharmacy ...

This was the stock's second consecutive day of losses.

It's a vote of confidence in Joyner, who took the helm following the ouster of former CEO Karen Lynch.

CVS Health ( CVS 1.57%) has been a huge outperformer this year. The stock is up about 79% so far in 2025 -- move than five ...

This milestone event will highlight the newly completed residential spaces inside the Prichard building and showcase the next ...